Lisa Schnirring | News Editor | CIDRAP NewsJun 26, 2020At a cost of an estimated $31 billion, new vaccines, treatments, and diagnostics are urgently needed.
Huge global effort to fast-track COVID-19 tools advances
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Very few US adults getting new flu, COVID, RSV vaccines, even in nursing homes
- US respiratory virus activity remains low ahead of holiday season
- Antiviral COVID-19 drug molnupiravir tied to large drop in deaths in older patients
- Adults with migraines at higher risk of depression during pandemic, study shows